P-905. Applying Encounter-level Risk-Adjustment for Standardized Antimicrobial Administration Ratios (SAAR): Is it meaningful?
Open Forum Infectious Disease
Rebekah W Moehring, MD, MPH, FIDSA, FSHEA , Elizabeth Dodds Ashley, PharmD, MHS , Rachel Addison, MT (ASCP), MPH , Whitney Buckel, PharmD , Sara E Cosgrove, MD, MS , Eili Klein, PhD , Carlos Santos, MD, MPHS , Michael J Smith, M.D., M.S.C.E , Emily S Spivak, MD, MHS , William Trick, MD , David J Weber, MD, MPH , Congwen Zhao, Master of Biostatistics , Deverick J Anderson, MD, MPH , Ben Goldstein, PhD , Michael E Yarrington, MD, MMCi
Summary
When encounter-level risk adjustment was applied, O:E and percentile estimates changed ASP assessments. ASPs preferred encounter-level risk adjustment when asked about desire for future AU comparisons.
Citation
Moehring, Rebekah W., et al. “P-905. Applying Encounter-level Risk-Adjustment for Standardized Antimicrobial Administration Ratios (SAAR): Is it meaningful?.” Open Forum Infectious Diseases. Vol. 13. No. Supplement_1. US: Oxford University Press, 2026.